Your browser doesn't support javascript.
loading
Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.
Ha, Alison W; Sudhadevi, Tara; Ebenezer, David L; Fu, Panfeng; Berdyshev, Evgeny V; Ackerman, Steven J; Natarajan, Viswanathan; Harijith, Anantha.
Affiliation
  • Ha AW; Department of Biochemistry, University of Illinois, Chicago, Illinois.
  • Sudhadevi T; Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
  • Ebenezer DL; Department of Pharmacology, University of Illinois, Chicago, Illinois.
  • Fu P; Department of Pharmacology, University of Illinois, Chicago, Illinois.
  • Berdyshev EV; Department of Medicine, National Jewish Health, Denver, Colorado.
  • Ackerman SJ; Department of Biochemistry, University of Illinois, Chicago, Illinois.
  • Natarajan V; Department of Pharmacology, University of Illinois, Chicago, Illinois.
  • Harijith A; Department of Medicine, University of Illinois, Chicago, Illinois.
Am J Physiol Lung Cell Mol Physiol ; 319(3): L497-L512, 2020 09 01.
Article in En | MEDLINE | ID: mdl-32697651

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Bronchopulmonary Dysplasia / Hyperoxia / Methanol / Airway Remodeling Limits: Animals Language: En Journal: Am J Physiol Lung Cell Mol Physiol Journal subject: BIOLOGIA MOLECULAR / FISIOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidines / Bronchopulmonary Dysplasia / Hyperoxia / Methanol / Airway Remodeling Limits: Animals Language: En Journal: Am J Physiol Lung Cell Mol Physiol Journal subject: BIOLOGIA MOLECULAR / FISIOLOGIA Year: 2020 Document type: Article Country of publication: Estados Unidos